Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sanofi (SNYNF)

Sanofi (SNYNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 14.69
  • Price/Book 2.10
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.8100 +3.20%
on 12/16/24
99.0300 -4.32%
on 11/29/24
-1.9616 (-2.03%)
since 11/18/24
3-Month
91.8100 +3.20%
on 12/16/24
115.7970 -18.18%
on 09/20/24
-18.9340 (-16.65%)
since 09/19/24
52-Week
90.4500 +4.75%
on 02/14/24
119.6500 -20.81%
on 09/11/24
-1.2220 (-1.27%)
since 12/19/23

Most Recent Stories

More News
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024

The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024

KLKBY : 4.2850 (-16.80%)
PADEF : 0.1828 (-16.53%)
ADOOY : 12.6700 (+9.22%)
PTAIY : 5.9600 (+0.76%)
PTAIF : 0.2955 (-19.15%)
PTCAY : 62.6100 (+67.18%)
SMGBF : 1.5300 (+1.32%)
SNY : 47.71 (+0.44%)
SNYNF : 94.7500 (-3.95%)
Informatica soars on its AI-powered data management cloud growth

Enterprise cloud data management software provider Informatica Co. (NASDAQ: INFA) saw its shares surge 23% on its impressive Q3 2023 earnings report. The compa

F : 9.88 (+1.44%)
PG : 168.06 (-0.67%)
INFA : 26.86 (+2.79%)
AMZN : 224.92 (+0.73%)
INTC : 19.52 (+2.41%)
SNYNF : 94.7500 (-3.95%)
SNY : 47.71 (+0.44%)
SAN : 4.51 (-0.66%)
SHEL : 60.64 (-0.23%)
SHEL.LN : 2,394.500 (-0.46%)
RTX : 116.48 (+0.88%)
Pfizer and Sanofi shares fall, which one to scoop up?

Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows

PFE : 26.36 (+2.29%)
SNY : 47.71 (+0.44%)
SNYNF : 94.7500 (-3.95%)
SAN : 4.51 (-0.66%)
MDCO : 84.90 (-0.07%)
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

SDGR : 19.44 (+0.73%)
GOOG : 192.96 (+1.72%)
NVDA : 134.70 (+3.08%)
SAN : 4.51 (-0.66%)
SNY : 47.71 (+0.44%)
SNYNF : 94.7500 (-3.95%)
RXRX : 6.03 (-0.99%)
EXAI : 4.84 (+3.20%)
BMY : 57.33 (+1.83%)
Exscientia is the Sniper of the AI Drug Discovery Industry

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

EXAI : 4.84 (+3.20%)
GGRGF : 18.5000 (+2.78%)
SNYNF : 94.7500 (-3.95%)
SNY : 47.71 (+0.44%)
RXRX : 6.03 (-0.99%)
BMY : 57.33 (+1.83%)
NVDA : 134.70 (+3.08%)
SDGR : 19.44 (+0.73%)
SFTBF : 55.0000 (-6.72%)
DarioHealth is an AI-Powered Digital Therapeutics Play

DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic

DRIO : 0.8000 (+8.09%)
AMWL : 7.87 (+0.38%)
CVS : 44.36 (+1.32%)
DXCM : 80.04 (+5.57%)
SNY : 47.71 (+0.44%)
SAN : 4.51 (-0.66%)
SNYNF : 94.7500 (-3.95%)
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing

SINGAPORE, Dec 6, 2022 - (ACN Newswire) - Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National...

GSK.LN : 1,308.500 (-1.02%)
0A87.LN : 13.120 (+0.61%)
SNY : 47.71 (+0.44%)
GSK : 33.60 (+0.51%)
TAK : 13.10 (+0.69%)
SNYNF : 94.7500 (-3.95%)
TKPHF : 26.0000 (+4.54%)

Business Summary

Sanofi was incorporated under the laws of France in 1994 as a société anonyme, a form of limited liability company. It is a healthcare company, engaged in the research, development, manufacture and marketing of healthcare products. Its principal activities include Pharmaceuticals, Human Vaccines...

See More

Key Turning Points

3rd Resistance Point 94.7500
2nd Resistance Point 94.7500
1st Resistance Point 94.7500
Last Price 94.7500
1st Support Level 94.7500
2nd Support Level 94.7500
3rd Support Level 94.7500

See More

52-Week High 119.6500
Fibonacci 61.8% 108.4956
Fibonacci 50% 105.0500
Fibonacci 38.2% 101.6044
Last Price 94.7500
52-Week Low 90.4500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar